BCM
GRCE

Bayesian Capital Management’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bayesian Capital Management’s Portfolio GRCE Stock Details GRCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-502
Closed -$46K – 778
2019
Q3 		$46K Buy
+502
New +$46K 0.01% 493